Renumathy Dhanasekaran is a Gastroenterology physician affiliated with Stanford University. OpenAlex indexes 224 publications with 44,903 citations (h-index 60); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- COVID-19 in Patients With Chronic Liver Diseases
Sponsor: Stanford University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
2 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Dysregulated Complement Pathway in Macrophage Reprogramming and Progression of HCC in MASH
Stanford University
FY2026$600,616R37CA296642 - Dysregulated Complement Pathway in Macrophage Reprogramming and Progression of HCC in MASH
Stanford University
FY2025$593,042R37CA296642 - Functional Proteomic Analysis and Biomarker Identification in a Novel Mouse Model of Metastatic Hepatocellular Carcinoma (HCC)
Stanford University
FY2022$202,144K08CA222676
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma
Journal of Hepatology
2023 - The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
Nature Reviews Clinical Oncology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Charles Debattista, MD
Stanford University
Rayhan Lal, MD
Stanford University
Michael Amylon, MD
Stanford University
Kimberly Dequattro, MD, MM
Stanford University
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”